NICE’s track record in cancer drugs: the impact of the CDF and interim funding

20 August 2019 - Cancer drugs and the decisions made by the UK’s NICE have been subject to much scrutiny ...

Read more →

Breast cancer patients to have further NICE approved drug combination option on Cancer Drugs Fund

17 July 2019 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on ...

Read more →

Petition for national cancer agency gathers steam

25 June 2019 - A petition launched in support of a national cancer agency has so far gathered more than ...

Read more →

The Cancer Drugs Fund in practice and under the new framework

12 June 2019 - The Cancer Drugs Fund was established in 2010 to improve access to treatments not routinely available. ...

Read more →

NICE appraisal for BMS kidney cancer immunotherapy combination

5 April 2019 - NICE has issued a Final Appraisal Determination endorsing NHS use of an Opdivo (nivolumab) and Yervoy ...

Read more →

Promising lung cancer treatment approved for Cancer Drugs Fund

28 March 2019 - A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, ...

Read more →

Tesaro's ovarian cancer drug Zejula added to Cancer Drugs Fund

1 June 2018 - Tesaro's ovarian cancer drug Zejula (niraparib), the first PARP inhibitor shown to be effective in patients ...

Read more →

Pfizer's Xalkori makes it onto Cancer Drugs Fund

31 May 2018 - NICE has published draft guidance recommending that Pfizer's Xalkori (crizotinib) to treat ROS1-positive advanced non-small-cell lung ...

Read more →

NICE says OK to Keytruda for bladder cancer via the Cancer Drugs Fund

16 March 2018 - Becomes the first immunotherapy recommended for urothelial cancer after chemotherapy. ...

Read more →

Once a day pill for ovarian cancer could be made available on the CDF

8 February 2018 - NICE has invited Tesaro to submit a proposal for including niraparib (Zejula) in the Cancer Drugs Fund ...

Read more →

Patients to benefit from myeloma treatment through CDF deal

7 February 2018 - Up to 1,600 patients with multiple myeloma could benefit from a new oral pill after NICE recommends ...

Read more →

CDF to save NHS £140m over five years

31 January 2018 - At least £140 million is expected to be released into the NHS over the next five ...

Read more →

Roche’s Tecentriq available via CDF

7 December 2017 - Roche’s Tecentriq will be available on the NHS in England via the Cancer Drugs Fund for ...

Read more →

Merck invited to submit a CDF proposal for Merkel cell cancer drug

27 November 2017 - NICE has asked Merck to submit a Cancer Drugs Fund proposal for an immunotherapy called avelumab. ...

Read more →

Roche’s skin cancer drug Erivedge pulled from CDF

13 October 2017 - Roche’s Erivedge could be removed from the Cancer Drugs Fund within months after the National Institute ...

Read more →